Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseAdoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord bloodImpact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesIncreased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host DiseaseValidation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.Thinking out of the box--new approaches to controlling GVHD.Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.A novel and rapid method to quantify Treg mediated suppression of CD4 T cells.Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.Human CD4- invariant NKT lymphocytes regulate graft versus host disease
P2860
Q28076264-269EAA3B-DF84-4F11-8215-F1E99624063EQ35582326-81299BD7-E297-4CA9-96A3-650373C0C895Q35670693-D2426BED-7142-46FD-9C1F-A9042EBBE331Q35738486-E47CD359-20F9-4C9E-B8F9-115364D3F729Q36036340-F7C2F4EC-78D4-4632-89C1-08BC41A4F03EQ36220062-70C0308A-782E-477F-8714-E7E1DF983FBDQ36685390-6128F36F-9383-4563-B9BD-7BD7790DFA8DQ37618811-DEB15ED6-FE73-459C-831D-F7F787BF40E2Q37655544-DECD9F85-F202-4E2F-A93D-8407F7CC7A74Q38175862-6B17C968-CCBA-4DE4-8DBB-F4C6A48F7D1BQ38714694-0C3E0FAA-F3C8-491C-8BC2-508DCB9FA8E2Q40158863-80C8C813-02AF-4FC7-AEEE-6277B23F8751Q46717839-070360D1-B97C-4FAC-A139-13D00C19B763Q47161119-C2D0727D-3124-49FD-84DD-A4F555896E4DQ54937398-975408BB-F7B2-492F-96B6-ACBE685227EAQ58129678-9421B9BA-2035-4F35-9308-50C4B7FDA7E2
P2860
Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@en
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@nl
type
label
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@en
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@nl
prefLabel
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@en
Infusion of clinical-grade enr ...... eic graft-versus-host disease.
@nl
P2093
P2860
P356
P1433
P1476
Infusion of clinical-grade enr ...... neic graft-versus-host disease
@en
P2093
Anne-Marie Chantillon
Chantal Lechanteur
Etienne Baudoux
France Bruck
Frédéric Baron
Joan Somja
Laurence Seidel
Ludovic Belle
Muriel Hannon
Olivier Giet
P2860
P304
P356
10.1111/TRF.12279
P50
P577
2013-06-17T00:00:00Z